{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:19Z","timestamp":1790937079824,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS056224"],"award-info":[{"award-number":["R01NS056224"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-15-00184"],"award-info":[{"award-number":["19-15-00184"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-021-01349-1","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:02:47Z","timestamp":1641168167000},"page":"742-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2"],"prefix":"10.1007","volume":"21","author":[{"given":"Polina A.","family":"Egorova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya B.","family":"Bezprozvanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"issue":"10","key":"1349_CR1","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","volume":"14","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa T, Oz G, Paulson HL. Spinocerebellar ataxias: prospects and challenges for therapy development. Nat Rev Neurol. 2018;14(10):590\u2013605.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1349_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12035-012-8348-8","volume":"47","author":"JJ Magana","year":"2013","unstructured":"Magana JJ, Velazquez-Perez L, Cisneros B. Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives. Mol Neurobiol. 2013;47(1):90\u2013104.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"1349_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrn.2017.92","volume":"18","author":"HL Paulson","year":"2017","unstructured":"Paulson HL, et al. Polyglutamine spinocerebellar ataxias - from genes to potential treatments. Nat Rev Neurosci. 2017;18(10):613\u201326.","journal-title":"Nat Rev Neurosci"},{"key":"1349_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-319-71779-1_8","volume":"1049","author":"DR Scoles","year":"2018","unstructured":"Scoles DR, Pulst SM. Spinocerebellar ataxia type 2. Adv Exp Med Biol. 2018;1049:175\u201395.","journal-title":"Adv Exp Med Biol"},{"key":"1349_CR5","doi-asserted-by":"crossref","unstructured":"Buijsen RAM, et al. Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias. Neurotherapeutics. 2019;16(2):263\u2013286.","DOI":"10.1007\/s13311-018-00696-y"},{"issue":"4","key":"1349_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s13311-019-00777-6","volume":"16","author":"PA Egorova","year":"2019","unstructured":"Egorova PA, Bezprozvanny IB. Molecular mechanisms and therapeutics for spinocerebellar ataxia type 2. Neurotherapeutics. 2019;16(4):1050\u201373.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1349_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00415-003-0976-5","volume":"250","author":"K Burk","year":"2003","unstructured":"Burk K, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol. 2003;250(2):207\u201311.","journal-title":"J Neurol"},{"issue":"12","key":"1349_CR8","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1007\/s00415-013-7138-1","volume":"260","author":"R Fancellu","year":"2013","unstructured":"Fancellu R, et al. Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2. J Neurol. 2013;260(12):3134\u201343.","journal-title":"J Neurol"},{"issue":"1","key":"1349_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12311-019-01079-5","volume":"19","author":"AF Gigante","year":"2020","unstructured":"Gigante AF, et al. The relationships between ataxia and cognition in spinocerebellar ataxia type 2. Cerebellum. 2020;19(1):40\u20137.","journal-title":"Cerebellum"},{"issue":"1","key":"1349_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13023-016-0447-6","volume":"11","author":"A Moriarty","year":"2016","unstructured":"Moriarty A, et al. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7. Orphanet J Rare Dis. 2016;11(1):82.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"1349_CR11","first-page":"1001","volume":"33","author":"HM Paneque","year":"2001","unstructured":"Paneque HM, et al. Type 2 spinocerebellar ataxia: an experience in psychological rehabilitation. Rev Neurol. 2001;33(11):1001\u20135.","journal-title":"Rev Neurol"},{"issue":"29","key":"1349_CR12","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","volume":"29","author":"J Liu","year":"2009","unstructured":"Liu J, et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J Neurosci. 2009;29(29):9148\u201362.","journal-title":"J Neurosci"},{"issue":"37","key":"1349_CR13","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.1523\/JNEUROSCI.1643-12.2012","volume":"32","author":"AW Kasumu","year":"2012","unstructured":"Kasumu AW, et al. Chronic suppression of inositol 1,4,5-triphosphate receptor-mediated calcium signaling in cerebellar purkinje cells alleviates pathological phenotype in spinocerebellar ataxia 2 mice. J Neurosci. 2012;32(37):12786\u201396.","journal-title":"J Neurosci"},{"issue":"1","key":"1349_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/s41598-018-37774-2","volume":"9","author":"CY Chuang","year":"2019","unstructured":"Chuang CY, et al. Modeling spinocerebellar ataxias 2 and 3 with iPSCs reveals a role for glutamate in disease pathology. Sci Rep. 2019;9(1):1166.","journal-title":"Sci Rep"},{"issue":"3","key":"1349_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nn1648","volume":"9","author":"JT Walter","year":"2006","unstructured":"Walter JT, et al. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci. 2006;9(3):389\u201397.","journal-title":"Nat Neurosci"},{"issue":"36","key":"1349_CR16","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","volume":"31","author":"VG Shakkottai","year":"2011","unstructured":"Shakkottai VG, et al. Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3. J Neurosci. 2011;31(36):13002\u201314.","journal-title":"J Neurosci"},{"issue":"44","key":"1349_CR17","doi-asserted-by":"publisher","first-page":"15533","DOI":"10.1523\/JNEUROSCI.2454-12.2012","volume":"32","author":"Z Gao","year":"2012","unstructured":"Gao Z, et al. Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice. J Neurosci. 2012;32(44):15533\u201346.","journal-title":"J Neurosci"},{"issue":"2","key":"1349_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/hmg\/dds427","volume":"22","author":"ST Hansen","year":"2013","unstructured":"Hansen ST, et al. Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2. Hum Mol Genet. 2013;22(2):271\u201383.","journal-title":"Hum Mol Genet"},{"issue":"32","key":"1349_CR19","doi-asserted-by":"publisher","first-page":"11292","DOI":"10.1523\/JNEUROSCI.1357-15.2015","volume":"35","author":"JM Dell'Orco","year":"2015","unstructured":"Dell\u2019Orco JM, et al. Neuronal atrophy early in degenerative ataxia is a compensatory mechanism to regulate membrane excitability. J Neurosci. 2015;35(32):11292\u2013307.","journal-title":"J Neurosci"},{"issue":"23","key":"1349_CR20","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1523\/JNEUROSCI.0891-15.2015","volume":"35","author":"MD Mark","year":"2015","unstructured":"Mark MD, et al. Spinocerebellar ataxia type 6 protein aggregates cause deficits in motor learning and cerebellar plasticity. J Neurosci. 2015;35(23):8882\u201395.","journal-title":"J Neurosci"},{"issue":"10","key":"1349_CR21","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.chembiol.2012.07.013","volume":"19","author":"AW Kasumu","year":"2012","unstructured":"Kasumu AW, et al. Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2. Chem Biol. 2012;19(10):1340\u201353.","journal-title":"Chem Biol"},{"issue":"6","key":"1349_CR22","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1152\/jn.00913.2015","volume":"115","author":"PA Egorova","year":"2016","unstructured":"Egorova PA, et al. In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model. J Neurophysiol. 2016;115(6):2840\u201351.","journal-title":"J Neurophysiol"},{"key":"1349_CR23","doi-asserted-by":"publisher","first-page":"102319","DOI":"10.1016\/j.ceca.2020.102319","volume":"93","author":"PA Egorova","year":"2021","unstructured":"Egorova PA, Gavrilova AV, Bezprozvanny IB. In vivo analysis of the spontaneous firing of cerebellar Purkinje cells in awake transgenic mice that model spinocerebellar ataxia type 2. Cell Calcium. 2021;93:102319.","journal-title":"Cell Calcium"},{"issue":"7","key":"1349_CR24","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1523\/JNEUROSCI.23-07-02600.2003","volume":"23","author":"MD Womack","year":"2003","unstructured":"Womack MD, Khodakhah K. Somatic and dendritic small-conductance calcium-activated potassium channels regulate the output of cerebellar Purkinje neurons. J Neurosci. 2003;23(7):2600\u20137.","journal-title":"J Neurosci"},{"issue":"16","key":"1349_CR25","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1113\/JP271897","volume":"594","author":"P Meera","year":"2016","unstructured":"Meera P, Pulst SM, Otis TS. Cellular and circuit mechanisms underlying spinocerebellar ataxias. J Physiol. 2016;594(16):4653\u201360.","journal-title":"J Physiol"},{"issue":"3","key":"1349_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/acn3.527","volume":"5","author":"DD Bushart","year":"2018","unstructured":"Bushart DD, et al. Targeting potassium channels to treat cerebellar ataxia. Ann Clin Transl Neurol. 2018;5(3):297\u2013314.","journal-title":"Ann Clin Transl Neurol"},{"issue":"21","key":"1349_CR27","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.1523\/JNEUROSCI.3582-09.2010","volume":"30","author":"K Alvina","year":"2010","unstructured":"Alvina K, Khodakhah K. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J Neurosci. 2010;30(21):7258\u201368.","journal-title":"J Neurosci"},{"issue":"21","key":"1349_CR28","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1523\/JNEUROSCI.6341-09.2010","volume":"30","author":"K Alvina","year":"2010","unstructured":"Alvina K, Khodakhah K. KCa channels as therapeutic targets in episodic ataxia type-2. J Neurosci. 2010;30(21):7249\u201357.","journal-title":"J Neurosci"},{"issue":"10","key":"1349_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","volume":"14","author":"S Romano","year":"2015","unstructured":"Romano S, et al. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14(10):985\u201391.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1349_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng0793-295","volume":"4","author":"S Gispert","year":"1993","unstructured":"Gispert S, et al. Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23\u201324.1. Nat Genet. 1993;4(3):295\u20139.","journal-title":"Nat Genet"},{"issue":"4","key":"1349_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1212\/WNL.55.4.569","volume":"55","author":"M Fernandez","year":"2000","unstructured":"Fernandez M, et al. Late-onset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology. 2000;55(4):569\u201372.","journal-title":"Neurology"},{"issue":"3","key":"1349_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/bpa.12412","volume":"27","author":"K Seidel","year":"2017","unstructured":"Seidel K, et al. On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3. Brain Pathol. 2017;27(3):345\u201355.","journal-title":"Brain Pathol"},{"issue":"4","key":"1349_CR33","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.bbrc.2016.07.020","volume":"483","author":"MD Mark","year":"2017","unstructured":"Mark MD, et al. Keeping our calcium in balance to maintain our balance. Biochem Biophys Res Commun. 2017;483(4):1040\u201350.","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"1349_CR34","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1111\/febs.14366","volume":"285","author":"PA Egorova","year":"2018","unstructured":"Egorova PA, Bezprozvanny IB. Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders. FEBS J. 2018;285(19):3547\u201365.","journal-title":"FEBS J"},{"key":"1349_CR35","doi-asserted-by":"crossref","unstructured":"Hisatsune C, Hamada K, Mikoshiba K. Ca2+ signaling and spinocerebellar ataxia. Biochim Biophys Acta Mol Cell Res. 2018;1865(11 Pt B):1733\u20131744.","DOI":"10.1016\/j.bbamcr.2018.05.009"},{"issue":"2","key":"1349_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/1570159X15666170529104000","volume":"16","author":"E Shimobayashi","year":"2018","unstructured":"Shimobayashi E, Kapfhammer JP. Calcium signaling, PKC gamma, IP3R1 and CAR8 link spinocerebellar ataxias and Purkinje cell dendritic development. Curr Neuropharmacol. 2018;16(2):151\u20139.","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"1349_CR37","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neuron.2005.02.012","volume":"45","author":"FE Hoebeek","year":"2005","unstructured":"Hoebeek FE, et al. Increased noise level of Purkinje cell activities minimizes impact of their modulation during sensorimotor control. Neuron. 2005;45(6):953\u201365.","journal-title":"Neuron"},{"issue":"1","key":"1349_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.expneurol.2012.04.015","volume":"236","author":"SE Dougherty","year":"2012","unstructured":"Dougherty SE, et al. Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease. Exp Neurol. 2012;236(1):171\u20138.","journal-title":"Exp Neurol"},{"key":"1349_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.expneurol.2012.11.015","volume":"240","author":"SE Dougherty","year":"2013","unstructured":"Dougherty SE, et al. Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington disease. Exp Neurol. 2013;240:96\u2013102.","journal-title":"Exp Neurol"},{"key":"1349_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fnins.2020.00279","volume":"14","author":"PA Egorova","year":"2020","unstructured":"Egorova PA, Gavrilova AV, Bezprozvanny IB. Ataxic symptoms in Huntington\u2019s disease transgenic mouse model are alleviated by chlorzoxazone. Front Neurosci. 2020;14:279.","journal-title":"Front Neurosci"},{"issue":"5","key":"1349_CR41","doi-asserted-by":"publisher","first-page":"e1006763","DOI":"10.1371\/journal.pgen.1006763","volume":"13","author":"TJ Isaksen","year":"2017","unstructured":"Isaksen TJ, et al. Hypothermia-induced dystonia and abnormal cerebellar activity in a mouse model with a single disease-mutation in the sodium-potassium pump. PLoS Genet. 2017;13(5):e1006763.","journal-title":"PLoS Genet"},{"key":"1349_CR42","doi-asserted-by":"crossref","unstructured":"Stay TL, et al. In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy. Dis Model Mech. 2019;13(2):dmm040840.","DOI":"10.1242\/dmm.040840"},{"issue":"3","key":"1349_CR43","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mds.28355","volume":"36","author":"DD Bushart","year":"2021","unstructured":"Bushart DD, et al. A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1. Mov Disord. 2021;36(3):622\u201331.","journal-title":"Mov Disord"},{"key":"1349_CR44","doi-asserted-by":"crossref","unstructured":"Dell'Orco JM, Pulst SM, Shakkottai VG. Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2. Hum Mol Genet. 2017;26(20):3935\u20133945.","DOI":"10.1093\/hmg\/ddx281"},{"key":"1349_CR45","doi-asserted-by":"publisher","first-page":"29489","DOI":"10.1038\/srep29489","volume":"6","author":"S Jayabal","year":"2016","unstructured":"Jayabal S, et al. 4-Aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6. Sci Rep. 2016;6:29489.","journal-title":"Sci Rep"},{"issue":"5","key":"1349_CR46","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s12311-018-0951-4","volume":"17","author":"PA Egorova","year":"2018","unstructured":"Egorova PA, Gavrilova AV, Bezprozvanny IB. In vivo analysis of the climbing fiber-Purkinje cell circuit in SCA2-58Q transgenic mouse model. Cerebellum. 2018;17(5):590\u2013600.","journal-title":"Cerebellum"},{"key":"1349_CR47","doi-asserted-by":"crossref","unstructured":"Kislin M, et al. Flat-floored air-lifted platform: a new method for combining behavior with microscopy or electrophysiology on awake freely moving rodents. J Vis Exp. 2014; (88): e51869","DOI":"10.3791\/51869"},{"issue":"7650","key":"1349_CR48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature22044","volume":"544","author":"DR Scoles","year":"2017","unstructured":"Scoles DR, et al. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2. Nature. 2017;544(7650):362\u20136.","journal-title":"Nature"},{"key":"1349_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1423-0127-18-54","volume":"18","author":"YK Chang","year":"2011","unstructured":"Chang YK, et al. Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells. J Biomed Sci. 2011;18:54.","journal-title":"J Biomed Sci"},{"issue":"3","key":"1349_CR50","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3727\/096368916X694373","volume":"26","author":"YA Tsai","year":"2017","unstructured":"Tsai YA, et al. Treatment of spinocerebellar ataxia with mesenchymal stem cells: a phase I\/IIa clinical study. Cell Transplant. 2017;26(3):503\u201312.","journal-title":"Cell Transplant"},{"issue":"14","key":"1349_CR51","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/hmg\/10.14.1511","volume":"10","author":"CJ Cummings","year":"2001","unstructured":"Cummings CJ, et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet. 2001;10(14):1511\u20138.","journal-title":"Hum Mol Genet"},{"issue":"41","key":"1349_CR52","doi-asserted-by":"publisher","first-page":"34908","DOI":"10.1074\/jbc.M506288200","volume":"280","author":"M Fujimoto","year":"2005","unstructured":"Fujimoto M, et al. Active HSF1 significantly suppresses polyglutamine aggregate formation in cellular and mouse models. J Biol Chem. 2005;280(41):34908\u201316.","journal-title":"J Biol Chem"},{"issue":"53","key":"1349_CR53","doi-asserted-by":"publisher","first-page":"55969","DOI":"10.1074\/jbc.M409062200","volume":"279","author":"D Helmlinger","year":"2004","unstructured":"Helmlinger D, et al. Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 mice. J Biol Chem. 2004;279(53):55969\u201377.","journal-title":"J Biol Chem"},{"issue":"1","key":"1349_CR54","doi-asserted-by":"publisher","first-page":"e3000596","DOI":"10.1371\/journal.pbio.3000596","volume":"18","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, et al. SK2 channels in cerebellar Purkinje cells contribute to excitability modulation in motor-learning-specific memory traces. PLoS Biol. 2020;18(1):e3000596.","journal-title":"PLoS Biol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-021-01349-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-021-01349-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-021-01349-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T11:12:51Z","timestamp":1661425971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-021-01349-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1007\/s12311-021-01349-1","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"assertion":[{"value":"18 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}